Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Riedmann, U; Chalupka, A; Richter, L; Werber, D; Sprenger, M; Willeit, P; Rijksen, M; Lodron, J; Høeg, TB; Ioannidis, JP; Pilz, S.
Underlying health biases in previously-infected SARS-CoV-2 vaccination recipients: a cohort study.
J Infect. 2025; 106497 Doi: 10.1016/j.jinf.2025.106497
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Pilz Stefan
Riedmann Uwe
Co-Autor*innen der Med Uni Graz
Chalupka Alena
Lodron Julia
Rijksen Marc
Sprenger Martin
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
OBJECTIVES: Observational studies may over- or under-estimate SARS-CoV-2 vaccine effectiveness (VE) depending on whether healthier (i.e. healthy vaccine effect (HVE)) or more ill individuals are preferentially vaccinated. To evaluate this issue, we compared non-COVID-19 mortality in vaccinated versus unvaccinated individuals. METHODS: This is a nationwide retrospective observational study in the entire adult population in Austria with previously documented SARS-CoV-2 infection with a follow-up from 2021 to 2023. Cox regression analyses were used to calculate hazard ratios (HRs) according to the number of SARS-CoV-2 vaccinations. We also performed matched analyses, where on each day, newly vaccinated individuals were matched with unvaccinated individuals based on age, sex and nursing home residency. RESULTS: In 4,324,485 eligible individuals, differences in non-COVID-19 mortality risk between vaccinated and unvaccinated were most prominent in the early periods and decreased thereafter. Matched analyses for the first two weeks after vaccination showed HRs below 0.5 for vaccinated versus unvaccinated individuals irrespective of vaccination numbers. Similar findings were retrieved for non-COVID-19, all-cause, and cancer deaths. Overall, COVID-19 deaths were significantly reduced in vaccinated individuals (VE of 26 to 53%). CONCLUSIONS: HVE for SARS-CoV-2 vaccines was strong early after vaccination and diminished over time. HVE should be considered when estimating VE.

Find related publications in this database (Keywords)
SARS-CoV-2
COVID-19
Mortality
National
Healthy vaccinee bias
Healthy vaccinee effect
© Med Uni Graz • Impressum